Back
ABBV
Description
Description
AbbVie Inc. (AbbVie) is a diversified research-based biopharmaceutical company. The Company is engaged in the research and development, manufacturing, commercialization and sale of medicines and therapies. It offers products in various therapeutic categories, including immunology products, which include Humira, Skyrizi and Rinvoq; oncology products, which include Imbruvica and Venclexta/Venclyxto; aesthetics products that include Botox Cosmetic, The Juvederm Collection of Fillers and others; neuroscience products, such as Botox Therapeutic, Vra...
Show more
NYSE/NASDAQ
Performance
Performance
$206.21
USD
▲ $92.19 (203.20%)
29th May 2023, 09:01 a.m.
1M
10Y
GRAPH
TABLE
GRAPH
TABLE
* US price history does not take into account stock splits
Quick facts
Quick facts
N/A Growth
5 year average annual growth
N/A
5 year average dividend yield
$15 AUD minimum investment
Due to minimum AUD to USD conversion
$0 USD median portfolio
Median amount held by the community
Costs
Costs
PURCHASE FEE
$6.50 AUD (or $5.50 with Pearler Prepay)
MANAGEMENT FEE
N/A
Community insights
Community insights
General statistics
0 investors hold ABBV
N/A average time between investments
N/A average holding per investor
1061 days since last community investment
Demographics
Income of investors
Less than 50k
-
50k - 100k
-
100k - 150k
-
150k - 200k
-
More than 200k
-
Age of investors
18-25 years old
-
26-34 years old
-
35-90 years old
-
Legal gender of investors
0% male
0% female
Related items
Related items
Pricing data reflects the most recent end-of-day traded price. Live pricing is shown at the time of buy/sell and may differ from what's displayed here. Other data is provided by our data partner, last updated on Wed Mar 25 2026, and may have changed since.
Learn more
Learn more
International shares and the Aussie investor: why looking beyond the ASX matters
READ
Long-term investing
First-time investors
Portfolios
If Australia is only 2% of global markets, where should the rest of your portfolio invest?
1 March 2026
・
Ana Kresina
・
6 min read
0 likes
・
0 views
AI investment advice: when it’s helpful vs when it may be harmful
READ
Financial independence
First-time investors
AI is reshaping how we invest, but can we trust its advice? Find out the pros, cons and when a human might be more relia...
13 March 2026
・
Cathy Sun
・
6 min read
0 likes
・
0 views
US stock
ASK & ANSWER
Shares & crypto
What are the best tech stocks to invest now in the US market?
K-Investor
•
July 27th, 2022
1 like
・
0 views
・
AU vs US shares
ASK & ANSWER
First-time investor
Hi, I’m fairly new to investing and this is a dumb question but what is the difference when investing in the AU shares v...
Molly Pearse
•
January 29th, 2023
3 likes
・
0 views
・
Aus v US shares - smart to invest in both?
ASK & ANSWER
Choosing Investments
I currently hold shares in various Australian ETFs including VDHG, NDQ, ETHI, etc. My question is whether I should also ...
Stephanie Varga
•
May 16th, 2023
2 likes
・
1 view
・